Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
UnitedHealth ( (UNH) ) has shared an update.
Between September 8 and September 10, 2025, UnitedHealth Group plans to meet with investors and analysts to reaffirm its adjusted 2025 earnings per share expectations, previously disclosed in July 2025. The company will discuss the impact of its recent acquisition of Amedisys, completed in August 2025, which is expected to slightly reduce adjusted earnings per share due to associated financing and integration costs.
The most recent analyst rating on (UNH) stock is a Buy with a $379.00 price target. To see the full list of analyst forecasts on UnitedHealth stock, see the UNH Stock Forecast page.
Spark’s Take on UNH Stock
According to Spark, TipRanks’ AI Analyst, UNH is a Outperform.
UnitedHealth’s overall stock score reflects strong financial performance and reasonable valuation, offset by technical indicators suggesting caution and challenges highlighted in the earnings call. The company’s strategic initiatives and governance improvements are positive, but cost pressures remain a significant concern.
To see Spark’s full report on UNH stock, click here.
More about UnitedHealth
UnitedHealth Group Incorporated operates in the healthcare industry, providing a wide range of health care products and services. The company is known for its focus on health insurance, health care services, and technology-driven health solutions.
Average Trading Volume: 15,992,994
Technical Sentiment Signal: Sell
Current Market Cap: $285.6B
See more data about UNH stock on TipRanks’ Stock Analysis page.